The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve." This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, shareholders and investors, and furthermore to society as a whole.

Company Profile

(March 1, 2016)

Corporate Name Shionogi Singapore Pte. Ltd.

10 Anson Road #34-14 International Plaza, Singapore 079903map
Tel : +65-62231617

Inquiry E-mail :
Adverse Events Reporting E-mail :

Parent Company

(March 31, 2015)

Corporate Name Shionogi & Co., Ltd.
Chief Executives President and CEO: Isao Teshirogi, Ph.D.
Established March 17, 1878
Incorporated June 5, 1919
Paid-in Capital ¥21,280 million
Head Office

1-8, Doshomachi 3-chome, Chuo-ku, Osaka 541-0045, Japan
Tel : +81-6-6202-2161 , Fax : +81- 6-6229-9596

Number of Employees Consolidated : 6,059
Category of Business Marketing and Manufacturing of Drugs
Type of Business Manufacturing and distribution of pharmaceuticals, diagnostic reagents and medical devices, etc.
Fiscal Year-End March 31
Amount of Sales Consolidated :¥273,991million (fiscal 2014 financial results)
Main Banks : Sumitomo Mitsui Banking Corporation
Mizuho Corporate Bank, Ltd.
Bank of Tokyo-Mitsubishi UFJ
Stock Code Number 4507
Stock (Securities) Listings Tokyo
Common Stock Number of shares issued : 351,136,165
Number of shareholders : 24,298